Show
Sort by
-
- PhD Thesis
- open access
Immune checkpoint inhibitors in gynecologic cancer : getting to prime T(I)ME?
(2025) -
- Miscellaneous
- open access
Pembrolizumab, radiotherapy, and an immunomodulatory five-drug cocktail in pretreated patients with persistent, recurrent, or metastatic cervical or endometrial carcinoma : results of the phase II PRIMMO study (vol 72, pg 475, 2022)
-
- Journal Article
- A1
- open access
Associations of the gut microbiome with outcomes in cervical and endometrial cancer patients treated with pembrolizumab : insights from the phase II PRIMMO trial
-
- Journal Article
- A1
- open access
Identification of potentially actionable genetic variants in epithelial ovarian cancer : a retrospective cohort study
-
Sexual health in Belgian cervical cancer survivors : an exploratory qualitative study
-
A breath of relief : navigating the resolution of unexplained respiratory failure
-
Vaginal morbidity, sexual functioning, and health-related quality of life in cervical cancer survivors : a cross-sectional multicenter study (VAMOS)
-
Performance of MRI for detection of >=T1b disease in local staging of endometrial cancer
-
- Journal Article
- A1
- open access
Completion surgery after intensity-modulated arc therapy for locally advanced cervical cancer : long-term follow-up and update on surgical outcome and oncologic results of a unique tertiary care single-center retrospective cohort
-
- Journal Article
- A1
- open access
Pembrolizumab, radiotherapy, and an immunomodulatory five-drug cocktail in pretreated patients with persistent, recurrent, or metastatic cervical or endometrial carcinoma : results of the phase II PRIMMO study